Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Financial Flexibility Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥174.88 Million (operating CF CN¥153.30 Million minus capex CN¥21.58 Million) represents 0% of total liabilities (CN¥1.96 Billion). Check 300026 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Chase Sun Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 300026 cash flow conversion.
Annual Financial Flexibility Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Tianjin Chase Sun Pharmaceutical Co Ltd. Explore 300026 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | CN¥1.05 Billion | CN¥852.24 Million | CN¥2.37 Billion | ▼ -30.2% |
| 2023 | 0.63x | CN¥1.88 Billion | CN¥1.53 Billion | CN¥2.97 Billion | ▲ +74.0% |
| 2022 | 0.36x | CN¥1.52 Billion | CN¥745.35 Million | CN¥4.17 Billion | ▲ +24.3% |
| 2021 | 0.29x | CN¥1.07 Billion | CN¥391.60 Million | CN¥3.65 Billion | ▲ +7.2% |
| 2020 | 0.27x | CN¥760.44 Million | CN¥196.66 Million | CN¥2.79 Billion | ▼ -54.2% |
| 2019 | 0.60x | CN¥807.12 Million | CN¥216.10 Million | CN¥1.36 Billion | ▼ -20.9% |
| 2018 | 0.75x | CN¥683.09 Million | CN¥388.19 Million | CN¥907.61 Million | ▼ -38.5% |
| 2017 | 1.22x | CN¥1.13 Billion | CN¥742.38 Million | CN¥919.62 Million | ▲ +76.1% |
| 2016 | 0.69x | CN¥863.60 Million | CN¥448.08 Million | CN¥1.24 Billion | ▲ +138.7% |
| 2015 | 0.29x | CN¥344.35 Million | CN¥121.00 Million | CN¥1.18 Billion | ▼ -39.3% |
| 2014 | 0.48x | CN¥328.31 Million | CN¥149.94 Million | CN¥684.85 Million | ▼ -1.3% |
| 2013 | 0.49x | CN¥250.79 Million | CN¥143.60 Million | CN¥516.40 Million | ▼ -46.0% |
| 2012 | 0.90x | CN¥373.38 Million | CN¥152.21 Million | CN¥415.19 Million | ▲ +7.8% |
| 2011 | 0.83x | CN¥298.15 Million | CN¥35.64 Million | CN¥357.47 Million | ▼ -4.5% |
| 2010 | 0.87x | CN¥159.14 Million | CN¥46.25 Million | CN¥182.14 Million | ▼ -36.2% |
| 2009 | 1.37x | CN¥184.88 Million | CN¥135.06 Million | CN¥134.90 Million | ▼ -0.3% |
| 2008 | 1.38x | CN¥126.01 Million | CN¥77.74 Million | CN¥91.63 Million | ▲ +100.9% |
| 2007 | 0.68x | CN¥77.88 Million | CN¥72.01 Million | CN¥113.79 Million | ▲ +1230.2% |
| 2006 | 0.05x | CN¥4.34 Million | CN¥1.22 Million | CN¥84.34 Million | — |